Your next step

The AOM Practice Brief by Glivara Clinical

A pharmacist-led briefing for owners and leaders of obesity-medicine practices: the obesity-medication developments that matter, and what they may mean for clinical care, medication access, and clinic workflow.

  • New drugs, indications, formulations, and meaningful safety developments
  • Coverage, cash pricing, manufacturer programs, shortages, and access
  • Important trials, guidelines, and regulatory changes
  • Implications for initiation, titration, switching, monitoring, and follow-up
  • What practice owners should watch, verify, or prepare for

Monthly, plus occasional urgent updates when something major changes. First issue coming soon.

Not for patient information. See the Privacy Notice.

No thanks, back to Glivara Clinical